Trial Profile
A Randomized, Double-Blind Placebo Controlled Trial to Investigate Safety and Efficacy of SPM927 in Painful Diabetic Neuropathy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Apr 2015
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors UCB
- 27 Apr 2015 New trial record
- 25 Apr 2015 Results of pooled and subgroup analysis presented at the 67th Annual Meeting of the American Academy of Neurology.